Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 JST Share Tweet list Print This image provided by Eisai in January 2023 shows vials and packaging for ...

As a practicing physician who has cared for patients with Alzheimer’s disease and other dementias for more than two decades, ...

The drug, lecanemab, was approved by the FDA this summer. The UW study focuses on patients without symptoms who have early ...

A small company in Research Triangle Park received positive results for its treatment for Alzheimer's disease.

The US FDA has issued proposal guidance to assist companies developing new treatments for patients in the early stages of Alzheimer’s disease, before the onset of noticeable (overt) dementia.

Commissions we earn from partner links on this page do not affect our opinions or evaluations. Our editorial content is based on thorough research and guidance from the Forbes Health Advisory Board.

Anavex's Alzheimer's drug Blarcamesine demonstrates strong statistical significance in improving cognition among dementia patients as measured by one co-primary endpoint and one secondary endpoint.

Good afternoon, Chicago. It was spring 2017, and the developers of the Old Post Office project in the South Loop had serious ...

Nov. 30, 2023 — Researchers are collaborating on a novel approach to use neuroimaging and network modeling tools -- previously developed to analyze brains of patients in the clinic -- to ...

A study has found that Viagra—commonly prescribed to men with erectile dysfunction—could be a potential candidate for treating the degenerative disease. A 93-year-old who barely remembers his ...

As the sun sets, problems arise - especially for those affected by Alzheimer's disease. This is largely because a change in schedule can cause confusion. It's what the term 'sundowning' means.